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Background: The use of peripheral nerve blocks in patients with Charcot-Marie-Tooth (CMT) disease is scarcely
reported; however, when performed it has proven to be effective for postoperative pain control.
Methods: A distal catheter-based sciatic nerve block for postoperative pain control was offered to 27 consecutive CMT
patients scheduled for elective foot surgery. 18 of the 27 CMT patients consented to the offered sciatic nerve block.
Localization of the sciatic nerve was guided by a nerve stimulator. The threshold current required to generate a motor
response was assessed and a catheter inserted. Postoperative pain was assessed by recording the dose of analgesics to
maintain visual analog score < 3 the next 48 hours. On demand patients received boluses of ropivacaine (2 mg/mL) via
the catheter and/or analgesics in case of insufficient pain relief. Total postoperative ropivacaine dosage and analgesic
consumption were recorded. About one year after the block patients were contacted to report their actual status by
self-assessment.
Results: In 17 patients a catheter could be placed. In 7 patients placement of the catheter was difficult (several attempts,
high electrical impedance). Patients with nerve block had lower analgesics consumption compared to patients without a
block. Surprisingly, the 7 patients with “difficult” catheter-placement had the overall lowest ropivacaine and analgesics
consumption compared to all other patients with or without peripheral block. No anesthesia related complications were
reported by the questionnaire.
Conclusions: In our small series catheter-based distal sciatic block within CMT patients had safely been used for pain
relief up to three days. The infusion of local anesthetics via a catheter was not associated with any complication.
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Charcot-Marie-Tooth (CMT) disease is a heterogeneous
group of inherited peripheral neuropathies with an esti-
mated prevalence of 1 in 2500 people. The disease is
caused by duplication on chromosome 17p11.2 [1]. De-
myelination of peripheral nerves cause marked slowing of
nerve conduction velocity and a decrease in compound
motor and sensory nerve action potentials. Patients suffer
from slowly progressive distal muscle wasting, weakness
and sensory loss, first affecting the feet and legs [2]. Foot
deformities cause gait disturbances and balance problems.
To overcome these problems CMT patients often have to
undergo foot surgery to improve their walking ability.* Correspondence: hubert.schmitt@kfa.imed.uni-erlangen.de
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reproduction in any medium, provided the orPeripheral nerve blocks provide good postoperative anal-
gesia and support postoperative rehabilitation with a high
rate of patient satisfaction. Many anesthesiologists fear per-
manent neurological injury or aggravation of the under-
lying disease when performing regional anesthesia in
patients with pre-existing neuropathy [3,4]. In contrast, as
far as the authors know, there is no case published docu-
menting any adverse outcome following peripheral nerve
block in CMT patients. We therefore prospectively studied
the efficacy, safety and patient satisfaction of distal sciatic
block in CMT patients scheduled for foot surgery. In this
article we report on our experience in performing a distal
sciatic block in a small series of CMT patients.Methods
In our hospital all patients scheduled for foot surgery are
offered sciatic nerve block for acute postoperative painl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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from this procedure. Between January 2003 and November
2010, 27 consecutive patients, diagnosed with CMT and
scheduled to receive anesthesia for elective foot surgery
were considered eligible for sciatic nerve block for postop-
erative analgesia. The catheter-based nerve block was of-
fered to all 27 patients followed by detailed discussion
regarding procedure, potential benefits and possible risks.
18 of the 27 CMT patients consented to the offered sciatic
nerve block. The study was approved by the ethics com-
mittee of the Friedrich-Alexander University Erlangen-
Nuremberg and written informed consent was obtained
from all patients. For ethical reasons randomization of the
participants was not possible.
Anesthetic management
In the operation theatre all patients were monitored
throughout the procedure by electrocardiography, non-
invasive blood pressure, and pulse oximetry. After an intra-
venous access had been established patients who had
consented to neural block were placed in the lateral
position with the leg to be blocked at the top and ex-
tended at the knee joint. To block the distal sciatic
nerve the lateral popliteal fossa approach was used. All
blocks were performed by two anesthesiologists with
substantial expertise in regional anesthesia. After skin
preparation, a 18G insulated needle (Contiplex D sys-
tem, Braun Melsungen, Germany) was inserted about 8-
10 cm cephalad to the lateral femoral epicondyle in the
groove between the biceps femoris and the vastus later-
alis muscles. The needle was directed about 45° cepha-
lad until a dorsal or plantar flexion of the foot was
obtained. The initial stimulating current was set to
1.0 mA with impulse duration of 1.0 ms and a fre-
quency of 2 Hz. After establishing initial muscle con-
tractions the needle was carefully repositioned in order
to obtain the minimum current strength and duration
(threshold) - with first reducing stimulus duration before
current strength - necessary to generate visible muscle
contractions. This threshold just enough to generate a
twitch was recorded and the product of current and dur-
ation was calculated. The settings of the nerve stimulator,
number of attempts, technical problems and complications
were documented. Stimulus duration of 0.3 ms was applied
as cut-off value. If stimulus duration was higher the blockTable 1 Demographic data of the patients
Group Age (y) Height (cm) Weight (kg) Gende
(F/M)
Patients with
block n = 17
39 (18-59) 170 (160-183) 68 (50-86) 7/10
Patients without
block n = 10
20 (18-51) 173 (158-190) 69 (43-103) 5/5
The values are given as median (range) or number.was defined as “high threshold” block. Corresponding, in
“low threshold”-blocks the stimulus duration could be re-
duced below 0.3 ms.
The catheter (20G, Contiplex D system, Braun Melsungen,
Germany) was then inserted through the needle and ad-
vanced about 4-5 cm over the tip of the needle. Following
negative aspiration a test dose consisting of 5 ml of ropi-
vacaine (3.75 mg/mL) was administered through the cath-
eter. Given a negative test dose, a total dose of 20 ml of
ropivacaine (3.75 mg/mL) was given in aliquots through
the catheter.
General anesthesia was induced and maintained as total
intravenous anesthesia with propofol and remifentanil ti-
trated to effect except in two patients. These two patients
(both with peripheral block) specifically requested spinal
anesthesia. All patients without a peripheral block wished
general anesthesia. At the end of surgery and complete
emergence from anesthesia patients were transferred to
the post-anesthesia care unit.
Postoperative management
For the next 48 hours patient’s postoperative pain was
measured by the means of a numerical 11-point scale
(NRS) ranging from zero (no pain) to 10 (worst pain).
During this time patients provided with a sciatic nerve
catheter received on demand and up to 4 boluses of 20 ml
of ropivacaine (2 mg/mL) into the catheter. Prior the
bolus was given by an anesthesiologist patients were asked
whether motor function and sensitivity of the leg were as
“normal”. Patients without a regional block or with insuffi-
cient pain relief (NRS >3) by the regional block received
supplementary pain therapy by intravenous paracetamol
and piritramide. Total postoperative ropivacaine dosage
and total analgesic drug consumption of every patient
were recorded.
To identify any changes regarding their disorder all pa-
tients were contacted by phone about one year after sur-
gery. The patients were asked with the help of a
standardized basic questionnaire to assess their actual
status by self-assessment. The questions covered details
like ability to walk, and necessity of additional assist de-
vices. Patients were asked to classify the actual with the
pre-operative status as: improvement, no change, or
worsening. Patients with a peripheral block were asked if
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Patients with low threshold
block n = 10
0.3 (0.2–0.7) 0.1(0.1) 0.03 (0,02-0.07) 370 (120-720) 0.07 (0-0.28) 24 (0-59)
Patients with high threshold
block n = 7
1* (0.3-5) 1.0* (0.3-1.0) 0.6* (0.18-5) 100* (0-300) 0.05† (0-0.17) 0 (0-20)
Patients without
block n = 10
0.2 (0.03-0.34) 18 (0-49)
The values are given as median (range). Analgesics are given as total amount of requirement over 48 hours postoperatively.
*p < 0.05 group ‘low’ vs ‘high’ threshold; Mann–Whitney U test.
†p < 0.05 group ‘high threshold vs no block; Mann–Whitney U test.
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between patients with or without peripheral block using
Mann–Whitney U test. Statistical analysis was performed
using the STATA statistical package (STATA Corporation,
College Station, Tex). A p-value <0.05 was considered
significant.
Results
The demographic variables, including age, gender, weight,
height, time since CMT had been diagnosed, and ASA
classification are summarized in Table 1. There was no
significant difference regarding demographic variables be-
tween patients with or without a peripheral block. Accord-
ing to the cut-off value of 0.3 ms for stimulus duration
patients with peripheral block were divided into two
groups with high and low threshold. 7 out of the 17 pa-
tients have been allocated to the high-threshold group in-
cluding one patient were the catheter could not be placed
due to insufficient twitch elicitation. Table 2 depicts elec-
trophysiological data for peripheral nerve location. Com-
paring both groups with nerve blocks, patients with high
threshold blocks requested significant lower amounts of
ropivacaine, while there were no differences regarding
intravenous paracetamol and piritramide administration.
Comparing the amount of intravenous analgesics between
patients with and without nerve blocks, only patients with
high threshold blocks showed significant less demand of
piritramide. Table 2 shows all data regarding postoperative
pain management. 20 of the 27 patients responded to the
questionnaire one year after surgery. Details of the ques-






threshold block n = 10
7/1 none
Patients with high
threshold block n = 7
1/5 none
Patients without
block n = 10
The values are given as numbers.related complications were reported in the questionnaire
by the patients.
Discussion
In this study we investigated the efficacy, safety and pa-
tient satisfaction of a catheter-based distal sciatic block in
CMT patients. The results of this study suggest that per-
ipheral nerve block can safely be performed in patients
suffering from CMT. Application of local anesthetics via a
catheter up to three days provided sufficient analgesia
without any complication.
Patients with CMT disease suffer from muscle wasting
predominantly in the lower limbs. Hallmarks in electro-
physiological findings are decreased motor nerve conduc-
tion velocity and overall reduced electrical excitability [5].
Even though there are no conclusive publications docu-
menting the drawback of the use of regional anesthesia in
CMT patients many anesthesiologists raise serious con-
cerns over this theme. Regional anesthetic techniques in
CMT disease have been anecdotally reported by case re-
ports or small case series [6-10]. Remarkably, all these re-
ports document significant pain relief by regional
techniques, no side effects, and in many cases patient sat-
isfaction (as far as reported). Our finding that patients
without nerve block requested significant more analgesics
than patients with nerve block was not surprisingly. How-
ever, the most striking finding of our study was the fact
that patients with a high threshold (corresponding to high
impedance) during block performance showed the overall
lowest analgesic requirements. We speculate that different
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addition, there seems to be a high inter-individual variabil-
ity of sensitivity to pain among CMT patients unrelated to
the CMT type [11,12].
Electrical excitability and conduction velocity of periph-
eral nerves are intrinsically linked to an intact myelinated
axon of peripheral nerves. The documented loss of integ-
rity of the axon membrane in CMT [5] could explain the
high threshold current in some patients performing a
nerve block. In an experimentally study Tsui et al. [13]
documented a significant increase in the threshold current
to generate a motor response of a peripheral nerve if the
needle was placed intraneurally. We speculate that a
demyelinated nerve may in part mimic intraneural situ-
ation and so explain the different current thresholds re-
ported in this study.
Most feared by anesthesiologists considering regional
anesthesia in patients with pre-existing neurologic disor-
ders is possible worsening of the underlying disease by a
regional block. Reviewing the literature we found no re-
port documenting such a case in CMT. To get a survey
of the course of the disease in our patients we assessed
patients using a standardized questionnaire about one
year after anesthesia. Most of the patients reported an
improvement of quality of life compared to their pre-
operative status. Some patients reported no change of
their general status. Our questionnaire showed that ac-
ceptance of the peripheral block was closely associated
with the ease of nerve localization. The majority of pa-
tients with easy localization (low threshold) would wish
again a peripheral block; patient where several attempts
with high thresholds were necessary will refuse a periph-
eral block in future.
The fact that no anesthesia related complication was re-
ported encourages our view that if patients with CMT
want regional block anesthesiologists should meet this de-
mand. In so far our results confirm case reports and a case
series where the uneventful use of central and regional
anesthesia in CMT has been documented [6,7,10].
A limitation of this study is the fact that we have not
used ultrasound for placement of the catheter, now widely
accepted as gold standard. When designing and perform-
ing this study, ultrasound was not available at our institu-
tion. We are convinced that the use of ultrasound
probably may have reduced the number of attempts and
shorten the time for catheter placement.Conclusions
This study shows that in CMT patients a sciatic nerve
block can safely be performed and may help to reduce
postoperative opioid consumption. The infusion of local
anesthetics up to three days via a catheter was not associ-
ated with any complication.Competing interests
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